Introduction {#Sec1}
============

Human induced pluripotent stem cells (hiPSCs) can be generated from adult human dermal fibroblasts by transduction of a defined set of transcription factors to reprogram them back to an equivalent of the early embryonic state \[[@CR1]--[@CR4]\]. hiPSCs, resembling human embryonic stem cells (hESCs), possess remarkable self-renewal capacity and unquestioned potential to differentiate into genuine cardiomyocytes \[[@CR5], [@CR6]\]. Being genetically identical to donor patients, patient-specific iPSCs avoid potential immune rejection and do not have the ethical issues specific to hESCs \[[@CR3]\], thereby representing an attractive cell source for future cardiac regenerative therapy \[[@CR7]\]. However, the prerequisite to the ultimate clinical application is that hiPSC-derived cardiac derivatives display normal physiological characteristics. Although the electrophysiological properties of hiPSC-derived cardiomyocytes have been reported \[[@CR5], [@CR6], [@CR8], [@CR9]\], which are similar to those of hESC-derived cardiomyocytes and early fetal cardiomycoytes \[[@CR7], [@CR10]--[@CR12]\], there is paucity of data concerning the calcium handling properties of hiPSC-derived cardiomyocytes, the key process underlying the excitation-contraction coupling.

In adult cardiomyocytes, a small calcium influx through L-type calcium channels during systole triggers a large calcium release from the internal calcium store, sarcoplasmic reticulum (SR) through ryanodine receptors (RyR) \[[@CR13]\]. Calcium-induced calcium release (CICR) is the primary mechanism linking electrical excitation and mechanical contraction in cardiomyocytes. During diastole, calcium is actively removed out of cytosol, mainly through SR calcium-ATPase (SERCA) back into SR and sodium/calcium exchanger out of cells \[[@CR13]\]. It has been reported that ESC-derived cardiomyocytes exhibit immature calcium dynamics due to the underdeveloped SR and the developmental expression profiles of calcium handling proteins \[[@CR10], [@CR11], [@CR14]--[@CR18]\]. However, it remains unclear whether hiPSC-derived cardiomyocytes exhibit similar immaturity in calcium handling as hESC-derived cardiomyocytes. In fact, such immaturity may not only result in poor host-graft electromechanical integration when transplanted into recipient heart, but also lead to lethal arrhythmias. In this study, we examined the calcium handling properties of two hiPSC- (IMR90- and KEVIN-SIU (KS)1-hiPSCs) derived cardiomyocytes with confocal microscopy in comparison with two hESC lines (H7- and HES3-hESCs).

Methods {#Sec2}
=======

hiPSC and hESC Culture and Cardiac Differentiation {#Sec3}
--------------------------------------------------

We used hiPSC line, IMR90-iPSCs (iPS (IMR90)-1, clone 1, WiCell) (WiCell Research Institute, Madison, Wisconsin), KS1-iPSCs as generated by our group in feeder-free condition \[[@CR19]\], and human embryonic stem cell (hESC) line H7- and HES3-hESCs (National Institutes of Health, NIH code WA07 & ES03 respectively) (WiCell Research Institute, Madison, Wisconsin) for these following experiments. Undifferentiated cells were cultured on Matrigel™ (BD Biosciences, MA)-coated dishes with mTeSR™ medium (Stem Cell Technologies, BC, Canada). Cardiac differentiation was performed according to a published protocol \[[@CR20]\]. Briefly, cells were dissociated into clumps using 1 mg/ml Dispase (Invitrogen, CA, USA) and cultured in suspension using low attachment plates to form embryoid bodies. The embryoid bodies were transferred onto gelatin-coated plates in StemPro®-34 medium (Invitrogen, CA, USA) supplemented with 2 mM glutamine (Gibco, CA, USA), 4 mM monothioglycerol (Sigma-Aldrich, St. Louis, MO), 50 μg/ml ascorbic acid (Sigma-Aldrich, St. Louis, MO) and 0.5 ng/ml BMP4 (R&D). In addition, the medium was further supplemented with various cytokines according to the following sequence: post-plating day 1 to 4, 10 ng/ml BMP4, 5 ng/ml bFGF, and 3 ng/ml activin A (Stemgent, CA, USA); post-plating day 4 to 8, 150 ng/ml DKK1 (Gibco BRL, Karlsruhe, Germany) and 10 ng/ml VEGF; and after day 8, 150 ng/ml DKK1, 10 ng/ml VEGF (Peprotech, NJ, USA), and 5 ng/ml bFGF (Peprotech, NJ, USA).

Isolation of hiPSC- and hESC-derived Cardiomyocytes {#Sec4}
---------------------------------------------------

Differentiated hiPSC- and hESC-embryoid bodies containing beating outgrowths were micro-surgically dissected using a glass knife on post-plating day 21 as previously described \[[@CR14], [@CR21]--[@CR23]\]. Beating cells were dissociated in medium containing 1 mg/ml collagenase B and 60 U/ml DNase I (Roche Applied Sciences Penzberg, Germany) at 37°C for 30 min and were re-suspended in Kraftbrühe (KB) solution containing 85 mM KCl, 30 mM K~2~HPO~4~, 5 mM MgSO~4~, 1 mM EGTA, 2 mM Na~2~-ATP, 5 mM pyruvic acid, 5 mM creatine, 20 mM taurine, and 20 mM D-glucose at room temperature for 1 h. Cells were then plated onto 0.1% gelatin-coated glass coverslips and maintained with culture medium.

Measurement of Cytosolic \[Ca^2+^\] {#Sec5}
-----------------------------------

Cytosolic calcium transients were estimated in isolated cells using a confocal imaging system (Olympus Fluoview System version 4.2 FV300 TIEMPO) mounted on an upright Olympus microscope (IX71) as previously described \[[@CR14], [@CR16], [@CR17], [@CR24], [@CR25]\]. Briefly, cells were loaded with 1:1 (*v*/*v*) amount of 20% Pluronic®-F127 (Invitrogen, life technologies) and 5 μM Fluo-3 AM (Sigma-Aldrich, St. Louis, MO) dissolved in DMSO with stock concentration of 5 mM for 45 min at 37°C in Tyrode solution containing 140 mM NaCl, 5 mM KCl, 1 mM MgCl~2~, 1.8 mM CaCl~2~, 10 mM glucose and 10 mM HEPES at pH 7.4 \[[@CR14]\]. Calcium transients of single cardiomyocytes were recorded with a temporal resolution of the line scan at 274 frames per second. Sacroplasmic reticular (SR) calcium load was estimated from peak calcium release after the addition of caffeine (10 mM). All confocal calcium imaging experiments were performed within 48 h after isolation in order to minimize contamination of time-dependent changes in calcium handling property in culture. Raw data of fluorescence intensity was recorded by area vs. time mode (XYT) as a line plot, the calibration curve showed that there is linear relationship between fluo-3 intensity recorded with calcium concentration up to 630 nM \[Ca^2+^\]. Regarding to line scan images, they are recorded in line vs. time mode (XT). The data were then quantified as the background subtracted fluorescence intensity changes normalized to the background subtracted baseline fluorescence using Image J. Amplitudes, maximal upstroke and decay velocity of calcium transient were analyzed by Clampfit version 9.2.0.09. (Axon Instruments, Inc, Foster City, CA).

Reverse Transcription Polymerase Chain Reaction (RT-PCR) {#Sec6}
--------------------------------------------------------

Total RNA from 2-week old hiPSC- and hESC-embryoid bodies was extracted with illustra RNAspin Mini kit (GE Healthcare, Buckinghamshire, UK). Reverse transcription was then performed using 0.5 μg RNA in a final volume of 20 μl, using QuantiTect® reverse transcription kit (Qiagen, Hilden, Germany, <http://www1.qiagen.com>) according to the manufacturer's instructions. Details of a panel of cardiac-specific genes and calcium handling protein genes are summarized in Table [1](#Tab1){ref-type="table"}. Quantitative PCR analysis was performed with real-time PCR Detector (Opticon 2 DNA Engine, MJ Research, Minnesota, USA) using the iQ SYBR Green Supermix (Bio-Rad Laboratories, Hercules, CA). For amplification, after initial holds for 5 min at 95°C, 50 cycles of 95°C for 15 s followed by corresponding annealing temperature for 30 s and 72°C for 30 s, melt curve analysis was performed. The relative quantification of PCR products was performed according to the $\documentclass[12pt]{minimal}
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Statistical Analysis {#Sec7}
--------------------

Continuous variables are expressed as mean ± standard deviation. Statistical comparisons were performed using Student's *t* test. Calculations were performed with SPSS (version 14.0). A *p-*value \<0.05 was considered statistically significant.

For additional methodological details, see the expanded methods section in the data supplement.

Results {#Sec8}
=======

Culture and Cardiac Differentiation of hiPSCs {#Sec9}
---------------------------------------------

Undifferentiated IMR-90 and KS1-hiPSCs were maintained in a feeder-free culture condition as previously described (Fig. [1](#Fig1){ref-type="fig"}) \[[@CR19], [@CR26]\]. Resembling to undifferentiated H7- and HES3-hESCs, hiPSC colonies expressed a panel of pluripotency markers including Oct-4, Nanog, stage-specific embryonic antigen (SSEA)-4, and tumor-rejection antigen (TRA)-1-60 (Fig. [1a to p](#Fig1){ref-type="fig"}). Spontaneous beating outgrowths were typically observed 14 days after cardiac differentiation induction in both hiPSC- and hESC-derived embryoid bodies (Supplemental video [1](#MOESM1){ref-type=""} and [2](#MOESM2){ref-type=""}). In immunocytochemical analysis of the cardiac-specific proteins: α-actinin and tropomyosin were abundantly expressed in IMR90- and KS1-hiPSC- and hESC-derived cardiomyocytes (Fig. [2a--h](#Fig2){ref-type="fig"}). The percentages of nodal-like, atrial-like and ventricular-like cardiomyocytes were not different significantly between hiPSC- and hESC-derived cardiomyocytes (Fig. [2i](#Fig2){ref-type="fig"} & j). Quantitative RT-PCR revealed that although the expressions of α-MHC and Nkx2.5 in two different lines of hiPSC-derived cardiomyocytes were comparable to those of hESC-dervied cardiomyocytes, β-MHC, the adult isoform, was expressed in much lower level in hiPSC-derived cardiomyocytes (Fig. [2k](#Fig2){ref-type="fig"} &l). Fig. 1Stem cell pluripotency markers expression in H7-, HES3-hESCs and IMR90-, KS1-hiPSCs. Tra-1-60 (**a**, **e**, **i** & **m**), Oct4 (**b**, **f**, **j** & **n**), SSEA-4 (**c**, **g**, **k** & **o**) and Nanog (**d**, **h**, **l** & **p**) and were expressed in both groups of cell linesFig. 2Cardiomyocytes differentiated from H7-, HES3-hESCs and IMR90-, KS1-hiPSCs were stained with two typical cardiac markers, alpha-actinin (**a**, **c**, **e** & **g**) and tropomyosin (**b**, **d**, **f** & **h**). The proportion of nodal-like, atrial-like, and ventricular-like cells in hESC- and hiPSC-derived cardiomyocytes as determined with action potential recordings with patch clamp (**i** &**j**). Quantitation of gene expression of cardiac proteins (**k** & **l**) in differentiated H7 hESCs vs. IMR90-iPSCs and HES3 hESCs vs. KS1-iPSCs. Homeobox protein Nkx-2.5 (Nkx2.5) and α/β-myosin heavy chain (α/β-MHC); Unpaired *t*-test was performed between H7 hESC-CMCs and IMR90 iPSC-CMCs as well as HES3 hESC-CMCs and KS1 iPSC-CMCs (*n* = 3; \*\**p* \< 0.005 and \*\*\**p* \< 0.0005)

hiPSC-derived Cardiomyocytes Exhibit Immature Spontaneous Calcium Transient {#Sec10}
---------------------------------------------------------------------------

We then evaluated the calcium handling properties of hiPSC-derived cardiomyocytes compared with those of human ESC-derived cardiomyocytes. Like hESC-derived cardiomyocytes, spontaneous rhythmic calcium transients were detected in hiPSC-derived cardiomycytes (Fig. [3a](#Fig3){ref-type="fig"}). However, hiPSC-derived cardiomyocytes exhibits more immature calcium handling properties than hESC counterparts (Fig. [3](#Fig3){ref-type="fig"}). Specifically, hiPSC-derived cardiomyocytes generated smaller amplitudes (IMR-90 iPSC-derived cardiomyocytes: 12.93 ± 0.79 F/F~o,~ and KS1-iPSC-derived cardiomyocytes: 9.10 ± 0.78 F/F~o~, vs. H7-ESC-derived cardiomyocytes: 20.28 ± 1.05 F/F~o~, and HES3-hESC-derived cardiomyocytes: 15.79 ± 1.25 F/F~o~; *p* \< 0.05; Fig. [3b](#Fig3){ref-type="fig"}), slower maximal upstroke (IMR-90 iPSC-derived cardiomyocytes: 0.02 ± 0.002 F/F~o~/s, and KS1-iPSC-derived cardiomyocytes: 0.013 ± 0.001 F/F~o~/s, vs. H7-ESC-derived cardiomyocytes: 0.03 ± 0.003 F/F~o~/s, HES3-hESC-derived cardiomyocytes: 0.03 ± 0.002 F/F~o~/s; *p* \< 0.05; Fig. [3c](#Fig3){ref-type="fig"}), and significant slower maximal decay velocity (IMR-90 iPSC-derived cardiomyocytes: −0.018 ± 0.001, and KS1-iPSC-derived cardiomyocytes: −0.009 ± 0.001 F/F~o~/s, vs. H7-ESC-derived cardiomyocytes: −0.014 ± 0.001, and HES3-hESC-derived cardiomyocytes: 0.019 ± 0.002 F/F~o~/s; *p* \< 0.05; Fig. [3d](#Fig3){ref-type="fig"}) in comparison with hESC-derived cardiomyocytes. Fig. 3Representative tracing of calcium transients and 2-D calcium transients in **a** H7 & HES3 hESC derived cardiomyocytes (H7 & HES3 hESC-CMCs), IMR90 & KS1 hiPSC derived cardiomyocytes (IMR90 & KS1 hiPSC-CMCs). **b** Amplitude, **c** maximal upstroke velocity (*V*~max~ upstroke), and **d** maximal decay velocity (*V*~max~ decay) of calcium transients in the cardiomyocytes. Unpaired *t*-test was performed between H7 or HES3 hES-CMCs and the other two lines of iPS-CMCs (*n* = 10; *n* is corresponds to different individual cells derived from three different experiments) (\**p* \< 0.05, \*\**p* \< 0.005 and \*\*\**p* \< 0.0005)

Effects of Caffeine and Ryanodine on Calcium Transients of hiPSC-derived Cardiomyocytes {#Sec11}
---------------------------------------------------------------------------------------

To determine whether SR in hiPSC-derived cardiomyocytes is in fact functional or not, we investigated the effects of caffeine, a RyR2 opener, and ryanodine, a RyR2 blocker, on the calcium transients of hiPSC-derived cardiomyocytes. Figure [4](#Fig4){ref-type="fig"} shows that the application of caffeine (10 mM) via a perfusion system induced a single large calcium transient that decayed slowly in both hiPSC-derived cardiomyocytes and hESC-derived cardiomyocytes (Fig. [4a](#Fig4){ref-type="fig"}). In comparison with hESC-derived cardiomyocytes, the caffeine-induced calcium transients in hiPSC-derived cardiomyocytes exhibited significantly smaller peak amplitudes (IMR-90 iPSC-derived cardiomyocytes: 9.36 ± 1.14 F/F~o~, and KS1-iPSC-derived cardiomyocytes: 3.39 ± 0.57 F/F~o~, vs. H7-ESC-derived cardiomyocytes: 21.23 ± 0.65 F/F~o~, and HES3-hESC-derived cardiomyocytes: 18.31 ± 0.94 F/F~o~; *p* \< 0.05, *n* = 10; Fig. [4b](#Fig4){ref-type="fig"}) and a slower maximal delay velocity (IMR-90 iPSC-derived cardiomyocytes: 0.01 ± 0.002 F/F~o~/s and KS1-iPSC-derived cardiomyocytes: 0.001 ± 0.00 F/F~o~/s, vs. H7-ESC-derived cardiomyocytes: 0.023 ± 0.002 F/F~o~/s, and HES3-hESC-derived cardiomyocytes: 0.028 ± 0.01 F/F~o~/s; *p* \< 0.05, *n* = 10; Fig. [4c](#Fig4){ref-type="fig"}) as well as maximal upstroke (IMR-90 iPSC-derived cardiomyocytes: −0.003 ± 0.00 F/F~o~/s, and KS1-iPSC-derived cardiomyocytes: −0.001 ± 0.00 F/F~o~/s, vs. H7-ESC-derived cardiomyocytes: −0.007 ± 0.00 F/F~o~/s and HES3-hESC-derived cardiomyocytes: −0.007 ± 0.00 F/F~o~/s; *p* \< 0.05, *n* = 10; Fig. [4d](#Fig4){ref-type="fig"}). The caffeine induced calcium release in suggested the presence of functional SR in hiPSC-derived cardiomyocytes; however, the slower rate of calcium release may imply an impaired calcium release through RyR. Consistently, the application of ryanodine (10 μM) resulted in a smaller reduction in amplitude in hiPSC-derived cardiomyocytes (IMR-90 iPSC-derived cardiomyocytes: 16.75%, and KS1-iPSC-derived cardiomyocytes: 5.15%, vs. H7-ESC-derived cardiomyocytes: 47.95%, and HES3-hESC-derived cardiomyocytes: 63.18%, *p* \< 0.05, *n* = 10) than human ESC-derived cardiomyocytes (Fig. [5b--d](#Fig5){ref-type="fig"}). Taken together, these observations suggested the presence of functional internal calcium store with immature calcium release mechanisms. Fig. 4Representative tracing of caffeine-induced calcium release in **a** H7- & HES3-hESC derived cardiomyocytes (H7 & HES3 hESC-CMCs), IMR90- & KS1-hiPS derived cardiomyocytes (IMR90 & KS1 hiPSC-CMCs). **b** Amplitude, **c** maximal upstroke velocity (*V*~max~ upstroke), and **d** maximal decay velocity (*V*~max~ decay) of calcium transients in the cardiomyocytes. Unpaired *t*-test was performed between H7 or HES3 hES-CMCs and the other two lines of iPS-CMCs (*n* = 10; n is corresponds to different individual cells derived from three different experiments; \**p* \< 0.05, and \*\*\**p* \< 0.0001). *Arrow heads* indicated the time points that caffeine was addedFig. 5Representative tracing of ryanodine sensitive calcium release in **a** H7- & HES3-hES derived cardiomyocytes (H7- & HES3-hES CMCs) and IMR90- & KS1-hiPSC-derived cardiomyocytes (IMR90- & KS1-hiPS CMCs). **b** Amplitude, **c** maximal upstroke velocity (*V*~max~ upstroke), and **d** maximal decay velocity (*V*~max~ decay) of calcium transients in the cardiomyocytes. Unpaired *t*-test was performed between two different groups as indicted by *arrows* in the figure (*n* = 12; *n* is corresponds to different individual cells derived from three different experiments; \**p* \< 0.05 and \*\*\**p* \< 0.0001)

To further compare the temporal and spatial patterns of calcium transients of hiPSC-derived and hESC-derived cardiomyocytes, transverse line-scan images of calcium transient were performed. As we previously reported in mouse ESC-derived cardiomyocytes \[[@CR14]\], both hESC-derived and hiPSC-derived cardiomyocytes exhibited a U-shape calcium wave fronts as in typical feature of t-tubule-deficit cardiomyocytes: the rise of calcium in the periphery was faster than their cell centers (Fig. [6a and b](#Fig6){ref-type="fig"}). Fig. 6Transverse line-scan confocal of hiPSC- and hESC-derived cardiomyocytes. Representative tracings of temporal and spatial patterns of calcium transients of hiPSC-derived cardiomyocytes (**a**) and **b** hESC-derived cardiomyocytes, **c** Time delay in the initial calcium rise between cell center and cell periphery in hiPSC- and hESC-derived cardiomyocytes, and **d** Quantitation of gene expression of calcium handling proteins of differentiated H7 hES and IMR90-iPS (**a**) and HES3 hES and KS1-iPS (**b**). The fold of change was normalized to the cardiac marker, Nkx2.5 expression. Sodium-calcium exchanger-1 (NCX-1), ryanodine receptor 2 (RyR2), sarcoplasmic recticulum calcium-Ca^2+^ATPase 2a (SERCA2a), calsequestrin (CASQ2), junction (Jun) and triaden (Trd). Unpaired *t*-test was performed between differentiated H7 hESCs vs. IMR90-iPSCs and HES3 hESCs vs. KS1-iPSCs (*n* = 3; \**p* \< 0.05, \*\**p* \< 0.005, and \*\*\**p* \< 0.0005)

Furthermore, in addition to the rhythmic whole-cell calcium transient, there were more high-frequency sub-maximal-amplitude calcium transients observed in hiPSC-derived cardiomyocytes than human ESC-derived cardiomyocytes (25% vs. 8.3%, *p* \< 0.05, (*n* = 25)). These sub-maximal calcium transients represent local calcium events instead of a whole-cell event. hiPSC-derived cardiomyocytes exhibited more local calcium events than their human ESC counterpart, suggesting a less effective calcium induced calcium release mechanism.

Expression of Calcium Handing Proteins {#Sec12}
--------------------------------------

To decipher the molecular basis for the difference in calcium handling properties between hiPSC- and hESC-derived cardiomyocytes, the expressions of three calcium handling proteins (sodium calcium exchanger-1 (NCX1), RyR2, and SERCA2a) as well as the three cardiac SR luminal auxiliary proteins (calsequestrin, junctin, and triadin), which form a protein complex associated with RyR2 were quantified (Fig. [@CR6] and [@CR6]). As shown in quantitative reverse transcription polymerase chain reaction, expressions of RyR2 and SERCA2a was significantly lower in two cell lines of hiPSC-derived cardiomyocytes in compared to hESC counterpart (*p* \< 0.0005; *n* = 3) (Fig. [6d](#Fig6){ref-type="fig"}). In addition, among the three cardiac SR luminal auxiliary proteins, the expression of triadin and junctin were significantly lower in hiPSC-derived cardiomyocytes compared with hESC-derived cardiomyocytes (*p* \< 0.0005), while no significant differences in calsequestrin expressions was observed between the two cell lines (Fig. [6e](#Fig6){ref-type="fig"}).

Discussion {#Sec13}
==========

In this study, we report the measurement of whole-cell calcium transients as well as the temporal and spatial properties of cellular calcium gradients in IMR-90 and KS1-hiPSC-derived cardiomyocytes and compared with those of H7- and HES3-hESC-derived cardiomyocytes. The major two findings are as follow. First, although hiPSC-derived cardiomyocytes resembling to hESC counterpart express major SR-calcium handling proteins including RyR2, SERCA2a, and NCX-1 and exhibit typical whole-cell calcium transients that respond to caffeine and ryanodine, the CICR mechanism appears not as efficient as that of hESC-derived cardiomyocytes, indicating more immature SR-calcium handling. Second, in addition to more immature whole cell calcium transients, the spatial inhomogeneities in the temporal properties of calcium transients across the width of cardiomyocytes were more pronounced in hiPSC-derived cardiomyocytes than hESC counterpart.

Cardiomyocytes are the cellular workhorse for cardiac contractile function. Their loss in myocardial infarction is irreversible due to their limited regenerative capacity and often results in heart failure. Although cell-based therapy has been envisioned as a therapeutic strategy to regenerate myocardium, transplantation of immature cardiomyocytes results not only poor graft-host integration but may also lead to potential lethal arrhythmia, \[[@CR27], [@CR28]\] thereby functional characterization of the stem cell-derived cardiomyocytes represents the crucial first step toward ultimate clinical application. Recently, the electrophysiological properties of hiPSC-derived cardiomyocytes have recently been reported; \[[@CR5], [@CR6], [@CR8], [@CR9]\] the calcium handling properties of hiPSC-derived cardiomyocytes have not been studied in detail. In fact, the dynamic alteration of cytosolic calcium concentration plays the central role in cardiac excitation-contraction coupling. Upon membrane depolarization, the influx of calcium via L-type calcium channels triggers calcium release from the internal calcium store, SR via RyRs, which in turn initiates the mechanical contraction \[[@CR13]\]. After reaching the peak calcium transient, cytosolic calcium is actively removed from the cytosol, mainly through SERCA-2a back into SR and NCX-1 out of cells \[[@CR18]\]. However, it was shown as early as in 2005 by Dolnikov and co-workers that the functional properties related to intracellular calcium handling of hESC-derived cardiomyocytes differ significantly from adult cardiomyocytes due to immature SR capacity \[[@CR11]\]. In fact, cardiomyocytes derived from hESC exhibit immature calcium handling properties resembling to that of fetal cardiomyocytes, albeit expressing functional SR \[[@CR22]\]. Specifically, hESC-derived cardiomyocytes, though responsive to caffeine and ryanodine, exhibited smaller whole-cell peak amplitude, slower upstroke and decay in calcium transient in comparison to adult cardiomyocytes \[[@CR10], [@CR11], [@CR22]\]. In our recordings, while spontaneous rhythmic calcium transients could be readily observed in hiPSC-derived cardiomyocytes, but these calcium transients were of even smaller amplitude, slower upstroke velocity, and slower reuptake compared with H7-hESC-derived cardiomyocytes. In addition, hiPSC-derived cardiomyocytes were less responsive to the application of ryanodine, indicating immature functioning SR relative to hESC counterpart. This may be partly related to the lower expression levels of major calcium handling proteins including SERCA2a and NCX-1 in hiPSC-derived cardiomyocytes.

Furthermore, in adult cardiomyocytes, RyRs are brought in close proximity to L-type calcium channels at the t-tubular system, allowing calcium wavefronts to quickly penetrate to the interior of the cells. In a stark contrast, ESC-derived cardiomyocytes exhibit spatial inhomogeneity in temporal properties of calcium transients across the width of the cells \[[@CR14], [@CR21]\]. Specifically, calcium wavefronts initiate earlier and reach the peak faster at the periphery of the ESC-derived cardiomyocytes than the center. As a result, the calcium wavefronts across the width of the cells as revealed by transverse line scan image typically show a U-shaped rise with a marked delay in peak between the cell periphery and the cell center \[[@CR14], [@CR21]\]. Recently, this inhomogeneity in the calcium release wavefront that reduces the efficacy of the calcium induced excitation-contraction coupling, have also been demonstrated in adult cardiomyocytes from failing heart \[[@CR29]--[@CR31]\]. In the present study, while both hiPSC- and hESC-derived cardiomyocytes exhibited this typical U-shaped rise in calcium wavefronts across the width of the cells, the delay between the cell periphery and the cell center was significantly longer in hiPSC-derived cardiomyocytes than hESC-counterpart. It has been suggested that this poor coupling between the calcium influx through L-type calcium channels and the calcium release from the SR through RyRs is secondary to the spatial separation of these ultrastructural organizations due to the lack of t-tubule \[[@CR14], [@CR21], [@CR29]--[@CR31]\]. At the t-tubule, triadin, a 32 kDa protein together with a set of interrelated and interacting proteins including junctin and calsequestrin forms complex with RyRs on the SR and the juxtaposed L-type calcium channels in the sarcolemma. In addition to serve as a physical linker between RyRs and L-type calcium channels, triadin has also been shown to regulate calcium release via modulating the gating function of RyRs \[[@CR32]\], as well as modifying the SR structure \[[@CR33]\]. In fact, in triadin null hearts, the ablation of triadin results in significant reduction in junctional SR proteins including RyR2, calsequestrin, and junctin, and 50% reduction in the contacts between junctional SR and t-tubules, which translate into reduced SR calcium release and impaired negative feedback of SR calcium release \[[@CR34], [@CR35]\]. In the present study, the expression of triadin was significantly lower in hiPSC-derived cardiomyocytes than that of hESC counterpart, which may partly explain the immature whole-cell calcium handling properties as well as the temporal inhomogeneity in calcium transient. As transplantation of immature cardiomyocytes results not only poor graft-host integration but also lethal arrhythmia \[[@CR27], [@CR28]\], in vitro manipulation of stem cell-derived cardiomyocytes is needed in order to yield mature cardiomyocytes. Exploiting various hypertrophic stimuli including triiodonthyronine, ouabain, apoA-I, and hypoxia, we have previously shown that calcium handling properties of ESC-derived cardiomyocytes could be driven more mature (or adult-like) for potential therapeutic use, and such changes were associated with the upregulation of major calcium handling proteins such in ESC-derived cardiomyocytes \[[@CR16], [@CR17], [@CR24], [@CR25]\]. The possibility of driven maturation of hiPSC-derived cardiomyocytes with these strategies requires further investigation.

Our study is limited by certain technological shortcomings. First, the confocal calcium imaging was not performed simultaneously with action potential recordings using patch clamp, thereby the chamber-identity of individual cardiomyocytes cannot be ascertained. Second, the calcium imaging was performed with Fluo-3 instead of ratiometric calcium indicators like Indo-1 or Fura-2, thus precluding the possibility of measuring the absolute intracellular calcium concentration.

Taken collectively, hiPSC-derived cardiomyocytes possess functional but immature SR. This finding has potential clinical implication. Although hiPSC-derived cardiomyocytes, avoiding the potential immune rejection and ethic issues peculiar to hESC, hold promise for cardiac regeneration, the immature calcium-handling properties of hiPSC-derived cardiomyocytes can result in poor functional integration and/or lethal arrhythmia after cellular transplantation, thus limiting their potential therapeutic applications. Thereby, it is highly desirable to develop strategies to drive functional maturation ex vivo.
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